Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AIRI - Up 11% Pre-Market/ Current Price $3.99
Receives Two Contracts Totaling $5.2 Million for US Navy E-2D Aircraft and F-35 Joint Strike Fighter Components
$WYY - Up 23% Pre-Market/ Current Price $2.24
Awarded $46 Million in IT and Security Contracts During Q2 2023
$WYY - Up 23% Pre-Market/ Current Price $2.24
Awarded $46 Million in IT and Security Contracts During Q2 2023
$TAOP - Up 32% Pre-Market/ Current Price $0.71
Taoping Contract Revenue Value Surges 95% YoY 1H '23
$TAOP - Up 32% Pre-Market/ Current Price $0.71
Taoping Contract Revenue Value Surges 95% YoY 1H '23
$CVM - Up 8% Pre-Market/ Current Price $2.66
Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer
$CVM - Up 8% Pre-Market/ Current Price $2.66
Reports Phase 3 Tumor PD-L1 Biomarker Data Demonstrate Multikine’s Increased Efficacy and Points to Potential for Combination With Checkpoint Inhibitors for Head & Neck Cancer
$SYBX - Up 9% Pre-Market/ Current Price $0.55
Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
$SYBX - Up 9% Pre-Market/ Current Price $0.55
Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
$IDXG - Up 11% Pre-Market/ Current Price $2.05
Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
$IDXG - Up 11% Pre-Market/ Current Price $2.05
Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
$NVVE - Up 14% Pre-Market/ Current Price $0.78
ntroduces Artificial Intelligence Into Its GIVe™ Software Platform Via Integration Into the FleetBox® Charge Management App
$NVVE - Up 14% Pre-Market/ Current Price $0.78
ntroduces Artificial Intelligence Into Its GIVe™ Software Platform Via Integration Into the FleetBox® Charge Management App
$CING - Up 42% Pre-Market/ Current Price $1.32
Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
$SOPA - Up 6% Pre-Market/ Current Price $0.56
Subsidiary, NextGen Retail Inc, to Acquire Indonesia's PT Inetindo Infocom to Create an Online and Offline Electronics and Gaming Retailer in the World's 4th Most Populous Economy
$SOPA - Up 6% Pre-Market/ Current Price $0.56
Subsidiary, NextGen Retail Inc, to Acquire Indonesia's PT Inetindo Infocom to Create an Online and Offline Electronics and Gaming Retailer in the World's 4th Most Populous Economy
$PTN - Up 8% Pre-Market/ Current Price $2.44
Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue Results
??31% growth over 2Q '23; 165% growth over 3Q '22
$PTN - Up 8% Pre-Market/ Current Price $2.44
Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue Results
??31% growth over 2Q '23; 165% growth over 3Q '22
$XOS - Up 6% Pre-Market/ Current Price $0.39
Failed to meet the Min Price Req to maintain a price of $1
They have been granted another extension till December 26 '23
$ELOX - Up 14% Pre-Market/ Current Price $4.69
Announces Publication Demonstrating the Power of its TURBO-ZM™ Platform to Target the Human Ribosome for Therapeutic Benefit
$ELOX - Up 14% Pre-Market/ Current Price $4.69
Announces Publication Demonstrating the Power of its TURBO-ZM™ Platform to Target the Human Ribosome for Therapeutic Benefit
$DFLI - Up 28% Pre-Market/ Current Price $1.95
Partners with World’s Largest Teardrop Manufacturer to Provide Full Lithium Power Systems
$CRKN - Up 25% Pre-Market/ Current Price $0.12
Secures an $85 million order from a client to work on a project based in Idaho
$CRKN - Up 25% Pre-Market/ Current Price $0.12
Secures an $85 million order from a client to work on a project based in Idaho
$DFLI -Up 28% Pre-Market/ Current Price $1.95.
Partners with World’s Largest Teardrop Manufacturer to Provide Full Lithium Power Systems
$DFLI -Up 28% Pre-Market/ Current Price $1.95.
Partners with World’s Largest Teardrop Manufacturer to Provide Full Lithium Power Systems
$BTTX - Up 33% Pre-Market/ Current Price $1.23
Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes
$BTTX - Up 33% Pre-Market/ Current Price $1.23
Receives FDA Authorization for AspyreRx™ to Treat Adults with Type 2 Diabetes
$GDTC -Up 300% from yesterdays close
A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US
Current Price $9.63
$GDTC -Up 300% from yesterdays close
A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US
Current Price $9.63
Video coverage of BBIG, ONDS, NGRBF
Huge Revenue Growth~Expansion~Dark Clouds
Zidar On Top & ?Hot Penny Stock~$BBIG~$ONDS~$NGRBF
Video coverage of BBIG
Huge Revenue Growth~Expansion~Dark Clouds
Zidar On Top & ?Hot Penny Stock~$BBIG~$ONDS~$NGRBF
$AURI - Auri, Inc Announces dividend
* Announces dividend of AURI Tokens 1 to 200 for every single share owned of AURI stock.
* The retirement of 300 million shares from the OS returned to treasury
* 9 billion shares reduced from the Authorized shares.
$AURI - Auri, Inc - Announces dividend
* Announces dividend of AURI Tokens 1 to 200 for every single share owned of AURI stock.
* The retirement of 300 million shares from the OS returned to treasury
* 9 billion shares reduced from the Authorized shares.
$FEMY - Femasys Announces FDA Approval for Permanent Birth Control
its IDE for the Pivotal Clinical Trial of FemBloc, a Non-Surgical Alternative for Women
OS-13.1m
$FEMY - Femasys Announces FDA Approval for Permanent Birth Control
its IDE for the Pivotal Clinical Trial of FemBloc , a Non-Surgical Alternative for Women
OS-13.1m
$SISI - Up 12% Pre-Market/ Current Price $0.37
Shineco, Inc.Subsidiary Receives Marketing Approval from China’s Regulatory Body for its Cardiac 5-Minute Test
$GVP - Up 11% Pre-Market/ Current Price $0.40
GSE Solutions Awarded up to $15M to Support Nuclear Power Plant Main Control Room Modernization Project
$JUPW - Up 58% Pre-Market/ Current Price $0.60
Jupiter Wellness Acquires World’s First Rapid Blood Alcohol Detox Drink “Safety Shot” to Launch Q4 2023: Lowers Blood Alcohol Content by up to 50% in Just 30 Minutes
$GRRR - Up 7% Pre-Market/ Current Price $5.05
Gorilla Technology Group A New Project That Is Twice The Size Of The Market Cap
Signs Contract to Deploy Massive Smart Government Project in Egypt